Literature DB >> 10930722

Behavioral characterisation of the flavonoids apigenin and chrysin.

P Zanoli1, R Avallone, M Baraldi.   

Abstract

The behavioral effects of acute administration of two flavonoids, apigenin and chrysin, contained in Matricaria chamomilla and in Passiflora incarnata, respectively, were studied in rats. The data demonstrate that in our experimental conditions, the two flavonoids were equally able to reduce locomotor activity when injected in rats at a minimal effective dose of 25 mg/kg. However, while chrysin exhibited a clear anxiolytic effect when injected at the dose of 1 mg/kg, apigenin failed to exert this activity. The sedative effect of these flavonoids cannot be ascribed to an interaction with GABA-benzodiazepine receptors, since it was not counteracted by the benzodiazepine antagonist Flumazenil. To the contrary, the anxiolytic effect of chrysin, which was blocked by the injection of Flumazenil, could be linked to an activation of the GABA(A) receptor unit.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930722     DOI: 10.1016/s0367-326x(00)00186-6

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  32 in total

1.  Three-Step Test System for the Identification of Novel GABAA Receptor Modulating Food Plants.

Authors:  Sümeyye Sahin; Volker Eulenburg; Wolfgang Kreis; Carmen Villmann; Monika Pischetsrieder
Journal:  Plant Foods Hum Nutr       Date:  2016-12       Impact factor: 3.921

Review 2.  Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

Review 3.  The globalization of traditional medicine in northern peru: from shamanism to molecules.

Authors:  Rainer W Bussmann
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-28       Impact factor: 2.629

4.  Passiflora incarnata L. (Passionflower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method.

Authors:  S-M Elsas; D J Rossi; J Raber; G White; C-A Seeley; W L Gregory; C Mohr; T Pfankuch; A Soumyanath
Journal:  Phytomedicine       Date:  2010-04-10       Impact factor: 5.340

5.  Multidimensional chemobehavior analysis of flavonoids and neuroactive compounds in zebrafish.

Authors:  Sean M Bugel; Robert L Tanguay
Journal:  Toxicol Appl Pharmacol       Date:  2018-02-27       Impact factor: 4.219

6.  Healing action of topical chamomile on 5-fluoracil induced oral mucositis in hamster.

Authors:  Vanessa C S Pavesi; Talita C C Lopez; Marco A T Martins; Manoel Sant'Ana Filho; Sandra K Bussadori; Kristianne P S Fernandes; Raquel A Mesquita-Ferrari; Manoela D Martins
Journal:  Support Care Cancer       Date:  2010-04-28       Impact factor: 3.603

7.  Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder.

Authors:  John R Keefe; Jun J Mao; Irene Soeller; Qing S Li; Jay D Amsterdam
Journal:  Phytomedicine       Date:  2016-10-24       Impact factor: 5.340

8.  A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder.

Authors:  Jay D Amsterdam; Yimei Li; Irene Soeller; Kenneth Rockwell; Jun James Mao; Justine Shults
Journal:  J Clin Psychopharmacol       Date:  2009-08       Impact factor: 3.153

9.  Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citratus.

Authors:  Romaiana Picada Pereira; Roselei Fachinetto; Alessandro de Souza Prestes; Robson Luiz Puntel; Gloria Narjara Santos da Silva; Berta Maria Heinzmann; Ticiane Krapf Boschetti; Margareth Linde Athayde; Marilise Escobar Bürger; Ademir Farias Morel; Vera Maria Morsch; João Batista Teixeira Rocha
Journal:  Neurochem Res       Date:  2008-10-14       Impact factor: 3.996

10.  Hexaaqua-(5,7-dihydr-oxy-4-oxo-2-phenyl-4H-chromene-8-sulfonato)calcium(II) 5,7-dihydr-oxy-4-oxo-2-phenyl-4H-chromene-8-sulfonate trihydrate.

Authors:  Bin Liu; Bo-Lun Yang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.